Yemil Atisha‐Fregoso

Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis

Yemil Atisha‐Fregoso, Susan Malkiel, Kristina M. Harris et al. · Arthritis & Rheumatology · 2020 · 197 citations · Full text

Interleukin‐6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus

Hilda Fragoso-Loyo, Yvonne Richaud‐Patín, Alejando Orozco-Narvaez et al. · Arthritis & Rheumatism · 2007 · 184 citations

Serum and Cerebrospinal Fluid Autoantibodies in Patients with Neuropsychiatric Lupus Erythematosus. Implications for Diagnosis and Pathogenesis

Hilda Fragoso-Loyo, Javier Cabiedes, Alejandro Orozco-Narváez et al. · PLoS ONE · 2008 · 170 citations · Full text

Loss of an IgG plasma cell checkpoint in patients with lupus

Jolien Suurmond, Yemil Atisha‐Fregoso, Emiliano Marasco et al. · Journal of Allergy and Clinical Immunology · 2018 · 60 citations · Full text

Autoimmune Disease, Systemic Lupus Erythematosus Treatment, Lupus +10

Diminished expression of complement regulatory proteins (CD55 and CD59) in lymphocytes from systemic lupus erythematosus patients with lymphopenia

Ignacio García-Valladares, Yemil Atisha‐Fregoso, Yvonne Richaud‐Patín et al. · Lupus · 2006 · 59 citations

Clinical Immunology, Immunohematology, Healthy Subjects +23